Salivary biomarkers of neurodegenerative and demyelinating diseases and biosensors for their detection

Ageing Res Rev. 2022 Apr:76:101587. doi: 10.1016/j.arr.2022.101587. Epub 2022 Feb 11.

Abstract

Salivary analysis is gaining increasing interest as a novel and promising field of research for the diagnosis of neurodegenerative and demyelinating diseases related to aging. The collection of saliva offers several advantages, being noninvasive, stress-free, and repeatable. Moreover, the detection of biomarkers directly in saliva could allow an early diagnosis of the disease, leading to timely treatments. The aim of this manuscript is to highlight the most relevant researchers' findings relatively to salivary biomarkers of neurodegenerative and demyelinating diseases, and to describe innovative and advanced biosensing strategies for the detection of salivary biomarkers. This review is focused on five relevant aging-related neurodegenerative disorders (Alzheimer's disease, Parkinson's disease, Amyotrophic Lateral Sclerosis, Huntington's disease, Multiple Sclerosis) and the salivary biomarkers most commonly associated with them. Advanced biosensors enabling molecular diagnostics for the detection of salivary biomarkers are presented, in order to stimulate future research in this direction and pave the way for their clinical application.

Keywords: Aging; Biosensors; Demyelinating diseases; Neurodegenerative diseases; Salivary biomarkers.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alzheimer Disease*
  • Biomarkers
  • Biosensing Techniques*
  • Demyelinating Diseases*
  • Humans

Substances

  • Biomarkers